Vaccines | Free Full-Text | Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
Monetary incentives increase COVID-19 vaccinations, nudges do not | CEPR
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study | Life Science Alliance
COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: ethical consideration
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents | NEJM
How can the public be persuaded to accept vaccine passports? | LSE COVID-19
SPI-B: Behavioural considerations for vaccine uptake in Phase 2 and beyond
Increasing Vaccine Uptake Among Seniors in Louisiana | Office of Evaluation Sciences
Nudges for COVID-19 voluntary vaccination: How to explain peer information? - ScienceDirect
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial - The Lancet
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques | Nature
Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA | Nature Human Behaviour
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021 | MMWR
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases | Respiratory Research | Full Text
Virtual control groups work to cut animal use in toxicity testing
Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques | PLOS ONE
Participation in vaccine control group "study" a potential scam - News 4
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks - eClinicalMedicine
Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany | PLOS ONE
Vaccines | Free Full-Text | Efficacy of a Smartphone Application to Promote Maternal Influenza Vaccination: A Randomized Controlled Trial
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population - eClinicalMedicine
Immunisation and vaccines
School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial | BMJ Open
